Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.3.0.814
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]        
Net sales (Note 2) $ 4,390 $ 5,130 $ 12,441 $ 13,098
Cost of sales (Note 2) 1,671 1,620 5,052 4,816
Gross profit 2,719 3,510 7,389 8,282
Operating expenses:        
Sales and marketing 699 875 4,221 4,724
Administration 1,222 1,917 4,834 6,228
Research and development $ 195 356 $ 675 907
Impairment charge 3,577 3,577
Total operating expense $ 2,116 6,725 $ 9,730 15,436
Income (loss) from operations 603 (3,215) (2,341) (7,154)
Interest expense, net (1) (1) (3) (4)
Income (loss) before income tax $ 602 $ (3,216) $ (2,344) $ (7,158)
Income tax (Note 4)
Net income (loss) $ 602 $ (3,216) $ (2,344) $ (7,158)
Basic income (loss) per share:        
Net income (loss) $ 0.04 $ (0.18) $ (0.14) $ (0.42)
Diluted income (loss) per share:        
Net income (loss) $ 0.04 $ (0.18) $ (0.14) $ (0.42)
Weighted average common shares outstanding:        
Basic 16,597 18,208 16,171 17,216
Diluted 16,972 18,208 16,171 17,216